Naldemedine-induced opioid withdrawal syndrome with severe psychiatric symptoms in an advanced cervical cancer patient without brain metastasis.

Mayumi IshidaMie HiraokaAyako YaguchiKoji SuganoNasako AdachiTomoko ItogaTomohito IshiguroHideki Onishi

Published in: Palliative & supportive care (2022)

If mental and behavioral abnormalities occur in patients receiving naldemedine, it is necessary to consider the possibility of opioid withdrawal syndrome as a differential diagnosis.

Keyphrases

case report
chronic pain
pain management
mental health
drug induced
high glucose
diabetic rats
early onset
resting state
oxidative stress
cerebral ischemia
multiple sclerosis
physical activity
depressive symptoms
subarachnoid hemorrhage
blood brain barrier